Evidence map›Paper›PMID 41074986›Full record

ArticleWorld journal of urology2025

Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York-Mason technique.

Sophia H van der Graaf, Esther M K Wit, Geerard L Beets, Brechtje A Grotenhuis, Ton A Roeleveld, Jakko A Nieuwenhuijzen, André N Vis, Pim J van Leeuwen, Henk G van der Poel

Abstract read
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sophia H van der GraafDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands. s.h.vandergraaf@amsterdamumc.nl.
Esther M K WitDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Geerard L BeetsDepartment of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Brechtje A GrotenhuisDepartment of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Ton A RoeleveldDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Jakko A NieuwenhuijzenDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
André N VisDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Pim J van LeeuwenDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.
Henk G van der PoelDepartment of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo present the outcomes of the York-Mason procedure for managing recto-urethral fistula (RUF) after robot-assisted radical prostatectomy (RARP).

methodsA single-center retrospective cohort study was conducted at the Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute. Between January 2011 and May 2024, 12 cases of RUF following RARP, all treated with the York-Mason technique, were identified. Initial treatment involved conservative management with prolonged catheterization. If unsuccessful, surgical intervention followed. The York-Mason procedure is a posterior transsphincteric approach, providing direct access to the fistula through healthy tissue, with precise layer-by-layer closure of the sphincter complex. Successful repair was defined as the absence of anal urinary loss, the absence of fecal material in the catheter bag or pneumaturia, and the absence of leakage on cystogram.

resultsOf the 12 cases of RUF, 10 occurred in patients who underwent RARP without radiotherapy (RARP-only), and 8 of these underwent York-Mason procedure as initial surgical treatment, achieving a 100% success rate after a median follow-up of 5.1 years (SD 2.9). The remaining two RARP-only patients initially underwent other surgical interventions, after which one achieved successful closure with subsequent York-Mason repair. The other two patients received both RARP and radiotherapy before fistula detection- one received radiotherapy prior to RARP, and one after. York-Mason was effective when radiotherapy preceded RARP.

conclusionThe York-Mason procedure provides promising results for managing RUFs in patients who have undergone RARP without salvage radiotherapy. Its effectiveness is particularly evident when used as the first surgical intervention.

Indexed as

Postoperative ComplicationsProstatectomyProstatic NeoplasmsRectal FistulaRobotic Surgical ProceduresUrethral DiseasesUrinary FistulaAgedCohort StudiesHumansMaleMiddle AgedRetrospective StudiesComplicationsProstate cancerRecto-urethral fistulasRobot-assisted radical prostatectomyYork–Mason technique

Identifiers

PMID41074986
PMCPMC12515200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.